FILTER

Refine your search with the following facets to narrow down your results.

2,227 Current news about the topic proteins

Cell Genesys Reports Potential Breakthrough in Antibody Production Technology

22-Apr-2005 - Cell Genesys, Inc. scientists reported the development of a proprietary gene expression technology that enables the production of full-length monoclonal antibodies at commercially relevant levels from a single production cell line. Moreover, the time required to develop cell lines that can be ...

antibodies arthritis biotechnology +12

PerkinElmer and Predictive Diagnostics announce Discovery of Blood Biomarkers for Alzheimer's Disease

22-Apr-2005 - PerkinElmer Inc. and Predictive Diagnostics, Inc., a wholly owned subsidiary of Large Scale Biology Corporation, announced that they have found a series of biomarkers that appear to differ in persons with Alzheimer's Disease compared to persons without cognitive impairment, using a simple blood ...

Alzheimer's disease biomarkers blood tests +5

Syngenta supports EU in targeted certification program for two animal feed maize products

19-Apr-2005 - Syngenta announced that it supports the EU in a targeted certification program for two animal feed maize products for importation from the USA . This program is intended to ensure that these two products, maize gluten and brewers grain for animal feed, are certified by an accredited laboratory ...

antibiotic resistance GeneScan maize +2

Celera Genomics and Abbott Announce Target Selection from Research Collaboration

19-Apr-2005 - Celera Genomics Group, an Applera Corporation business, and Abbott announced that two Celera antigen targets have been selected for further investigation by Abbott for therapeutic development. These are the first targets to be selected for advancement in the strategic collaboration established ...

Abbott antigens Applera +7

Biolex Forms Broad Strategic Alliance with Centocor to Develop and Manufacture Therapeutic Proteins

19-Apr-2005 - Biolex, Inc. announced a broad-based, multi-leveled strategic alliance with Centocor, Inc. to manufacture selected proteins using the Biolex LEX System(TM). The alliance will leverage certain key product candidates in Centocor's therapeutic protein pipeline, using Biolex' innovative method to ...

Johnson & Johnson milestone payments proteins +4

Pontifax Invests in Israeli Protein Expression Company - Protalix Biotherapeutics Ltd.

14-Apr-2005 - Protalix Biotherapeutics Ltd. ("Protalix") has announced that it has signed the final agreements with the Pontifax VC fund ("Pontifax"), which will invest in the Company. Pontifax shall invest $1 million in consideration for Series B preferred shares, and was granted an option to invest an ...

cell cultures clinical trials Expression +2

Geron and Exeter Life Sciences form joint venture for animal cloning technologies

08-Apr-2005 - Geron Corporation and Exeter Life Sciences, Inc. announced the formation of stART Licensing, Inc., a new company that will manage and license a broad portfolio of intellectual property rights related to animal reproductive technologies. This unique portfolio includes the foundational nuclear ...

agriculture antibodies biotechnology +10

Cardinal Health Receives Patent For Mammalian Cell Genetic Engineering Technology

08-Apr-2005 - Cardinal Health announced it has been granted its first patent for an innovative technology that will help in the mass production of biopharmaceuticals. The company received U.S. Patent No. 6,852,510, entitled "Host Cells Containing Multiple Integrating Vectors", for its gene product expression ...

Alzheimer's disease antibodies arthritis +10

Genomics and Proteomics to Increase the Efficiency of Drug Discovery and Development

07-Apr-2005 - While the United States is still the world leader, Europe is having a good deal of success in the field of advanced genomics and proteomics research. Significant government funding together with the presence of large pharmaceutical companies has made Europe a major competitor in the efforts to ...

biomarkers clinical trials diseases +21

Crucell Receives US Patent Covering its STAR(TM) Technology

06-Apr-2005 - Crucell N.V. announced that it has been granted a patent by the United States Patent and Trademark Office for its STAR(TM) technology. The newly issued patent is the first and basic patent in a portfolio pertaining to the STAR(TM) technology developed by professor Arie Otte of Chromagenics ...

cell cultures Crucell therapeutic proteins